Home
  • Our Company
    • Biopharmaceutical Acceleration Model®
    • Dynamic Assembly®
    • Kinetic™
    • Syneos One®
    • The Trusted Process®
    • Our Leadership
    • Our Vision, Mission and Values
    • Resource Library
    • Events
    • Awards
    • Site Relationships
    • Our Office Locations
  • Solutions
    • Clinical Development
      • Full Service
        • Decentralized Solutions
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World and Late Phase
        • Medical Device and Diagnostics
      • FSP 360
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Monitoring
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • AnswerSuite
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Deployment Solutions
      • Digital and Social Media
      • Full-Service Commercial
      • Health Economics and Outcomes Research
      • Medical Affairs Transformation
      • Medical Communications
      • Policy and Advocacy
      • Portfolio Strategy
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Selling Solutions
      • Training and Learning Solutions
      • Value and Access
    • Consulting
      • Commercial Advisory Group
        • Portfolio Strategy and Transactions
        • Health Economics and Outcomes Research
        • Product and Franchise Strategy
        • Value and Access
        • Customer and Digital Engagement
      • Scientific and Medical Affairs Advisory Group
        • Medical Affairs
        • Quality and Compliance
        • Regulatory
      • Risk and Program Management Advisory Group
        • REMS and Risk Management (PMO)
      • R&D Advisory Group
        • Research and Development
    • Syneos One®
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • Central Nervous System
        • CNS Analgesia
        • CNS Clinical Surveillance Team
        • CNS Neurology
        • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease and Vaccines
      • Ophthalmology
      • Respiratory
      • Women's Health
      • Oncology and Hematology
        • Targeted Therapies
        • Novel and Emerging Therapies
        • Immuno-Oncology
    • Cross-Functional Solutions
      • Biosimilars
      • Cell and Gene Therapy
      • Patient Voice
      • Pediatrics
      • Rare Diseases
    • Our Experience Hub
  • Insights Hub
  • Careers
  • インサイト ハブ
  • 中途採用
  • 新卒採用 (日本)
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Investigators
  • Transparency
  • Suppliers
    • Supplier Code of Conduct
    • Standard Contractual Clauses for Suppliers
    • Supplier Diversity and Inclusion
    • Supplier Terms and Conditions
  • Contact
  • English
  • Français Canadien
  • 日本語

Search form

Home Insights Hub The 2021 Health Trends Series Combating Complexity
Trends

Combating Complexity

March 18, 2021
Content 

We’re seeing a second wave of leaders and advocates working together to combat complexity in communication about healthcare and treatment options. This new tipping point is fueled by an important trifecta: the increasing personalization of medicine, stronger understanding of how people make healthcare decisions, and new challenges created by replacing many face-to-face conversations with phone lines and screens. The new science of engagement brings together plain language, behavioral insight and actionable steps to help patients and advocates make personal decisions with confidence.

Image or Video 

Combating Complexity.png

2021 Health Trends - Combating Complexity
Critical Question

Which of our clinical and commercial materials could use a fresh evaluation for relevance to advocates and patients?

Did you know...

Columns 
Content 
Image or Video 

Plain - Combating Complexity.png

Plain - Combating Complexity

Plain: Plain language summaries (PLS) are designed for patients and their supporters who are actively seeking scientific information. They translate dense clinical publications into non-technical language to fuel understanding. PLS are increasingly likely to launch with abstracts. At ESMO 2020, Pfizer launched each of its abstracts with a companion plain language summary. ClinicalTrialDataShare.com, from Syneos Health, catalogs all the publicly available clinical trial plain language summaries.

 

— Pfizer, 2020;
— Syneos Health, 2020

Content 
Image or Video 

Infodemic - Combating Complexity.png

Infodemic - Combating Complexity

Infodemic: Experts are saying simple, trusted scientific information is more important than ever as patients try to make decisions about COVID-19 trials and treatments/vaccines in the middle of culture wars. In fact, this infodemic is bringing to light how underestimated poor health literacy is as a public health problem. In Europe, for example, nearly half of adults have challenges with health literacy and lack key competencies to take care of their health and their loved ones. A similar review out of China, reported 28% of Beijingers have adequate health literacy to confidently address chronic and acute disease.

— The Lancet Public Health, 2020;
— Healio / HLRO, 2020

 

Download a PDF of This Content Below

The 2021 Health Trends Series
Acute Uncertainty
Retention Reboot
Enabled 
Download
Previous Next

Fill out the form below to download your requested Insights Hub Article.

*Required fields

By submitting this form, you agree to our Terms & Conditions and Privacy Policy of our website. You can withdraw your consent at any time. If you have any questions, please Contact Us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chapters

Chapter:
13
Privacy and Convenience
Chapter:
14
Retention Reboot
Chapter:
15
Acute Uncertainty
Chapter:
16
Combating Complexity
Chapter:
17
China: The New Pace Car of Change
Chapter:
18
Forming the Future Field

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »
Branded Logo
Subscribe to Our Newsletter Share

Related Content

The 2021 Health Trends Series
July 1, 2021
Acute Uncertainty
March 11, 2021
Retention Reboot
March 4, 2021
Interested in Syneos Health?
Get In Touch
Connect
  • LinkedInLinkedIn
  • TwitterTwitter
  • FacebookFacebook
  • InstagramInstagram

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. We support a diverse, equitable and inclusive culture. Contact Us

Our Headquarters
Corporate Headquarters
  • 1030 Sync Street
  • Morrisville, NC 27560
  •  
  • Phone: +1 919 876 9300
  • Fax: +1 919 876 9360
  • Toll-Free: +1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • 労働者派遣法に基づく情報公開
  • Careers
  • Study Participants
  • Media
  • Business Ethics Helpline
  • Events
  • Transparency
© 2022 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Notice
  • Privacy Shield
  • Online Tracking Opt-Out